Robot vs. human: can AI plan better prostate cancer radiation?
NCT ID NCT06625034
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase III trial tests whether an automated planning tool called RapidPlan can match or beat human-driven planning for prostate cancer radiation therapy. About 108 men with prostate cancer will be randomly assigned to one of two planning methods. The goal is to see if the automated approach leads to fewer serious side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Radiation therapy planning software (RapidPlan)
- What this could lead to
- If successful, this could show that automated planning reduces side effects and saves time compared to manual planning for prostate cancer radiotherapy.
- What could go wrong
- This is a phase III trial, but it focuses on planning methods, not a new drug or cure. The benefit may be small, and results may not apply to all centers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Arizona
RECRUITINGScottsdale, Arizona, 85259, United States
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mayo Clinic in Florida
NOT_YET_RECRUITINGJacksonville, Florida, 32224-9980, United States
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New PET tracer could reveal hidden prostate cancer
- New PET-MRI tracer could sharpen prostate cancer biopsy accuracy
- New PET tracer could spot cancers that standard scans overlook
- New urine test could spot prostate cancer earlier in High-Risk men
- AI-Powered MRI could revolutionize prostate cancer detection
- New imaging technique could sharpen radiation targeting in prostate cancer